Tag: U.S. Patent
LegoChem Biosciences Receives US Patent for Proprietary ConjuAll ADC Platform Technology
South Korean LegoChem Biosciences, earlier today confirmed that the Company was awarded a new U.S. Patent for ConjuAll™ technology, the company's proprietary ADC platform...
New Key Patent Covers Synaffix’s Glycan-Conjugated ADC Development Process
Synaffix, a Netherlands-based biotechnology company exclusively focused on the continued advancement of best-in-class ADC technology platforms has received a new key patent for their...
New Patents Awarded for Immunomedics’ Antibody-drug Conjugates Development Program
Earlier this week Immunomedics announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. Patent 9,492,566, the 32nd U.S. patent protecting the...
Immunomedics Receives U.S. patent for Labetuzumab Govitecan
Earlier this week Immunomedics announced the issuance of U.S. patent no. 9,226,973 for additional claims. Under the patent family “Dosages of immunoconjugates of antibodies and...
